JP2022502441A5 - - Google Patents
Info
- Publication number
- JP2022502441A5 JP2022502441A5 JP2021517342A JP2021517342A JP2022502441A5 JP 2022502441 A5 JP2022502441 A5 JP 2022502441A5 JP 2021517342 A JP2021517342 A JP 2021517342A JP 2021517342 A JP2021517342 A JP 2021517342A JP 2022502441 A5 JP2022502441 A5 JP 2022502441A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- optionally
- substituted
- residues selected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024118649A JP2024153742A (ja) | 2018-09-26 | 2024-07-24 | Ｃｃｒ３阻害剤を用いて、加齢性機能障害を治療するための方法および組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862737017P | 2018-09-26 | 2018-09-26 | |
| US62/737,017 | 2018-09-26 | ||
| PCT/US2019/052995 WO2020069008A1 (en) | 2018-09-26 | 2019-09-25 | Methods and compositions for treating aging-associated impairments using ccr3-inhibitors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024118649A Division JP2024153742A (ja) | 2018-09-26 | 2024-07-24 | Ｃｃｒ３阻害剤を用いて、加齢性機能障害を治療するための方法および組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022502441A JP2022502441A (ja) | 2022-01-11 |
| JP2022502441A5 true JP2022502441A5 (https=) | 2022-09-14 |
| JP7528065B2 JP7528065B2 (ja) | 2024-08-05 |
Family
ID=69953286
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021517342A Active JP7528065B2 (ja) | 2018-09-26 | 2019-09-25 | Ｃｃｒ３阻害剤を用いて、加齢性機能障害を治療するための方法および組成物 |
| JP2024118649A Pending JP2024153742A (ja) | 2018-09-26 | 2024-07-24 | Ｃｃｒ３阻害剤を用いて、加齢性機能障害を治療するための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024118649A Pending JP2024153742A (ja) | 2018-09-26 | 2024-07-24 | Ｃｃｒ３阻害剤を用いて、加齢性機能障害を治療するための方法および組成物 |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP3856195A4 (https=) |
| JP (2) | JP7528065B2 (https=) |
| KR (1) | KR20210065950A (https=) |
| CN (1) | CN112789044A (https=) |
| AU (1) | AU2019346456A1 (https=) |
| BR (1) | BR112021004938A2 (https=) |
| CL (1) | CL2021000724A1 (https=) |
| CO (1) | CO2021003713A2 (https=) |
| EA (1) | EA202190463A1 (https=) |
| IL (1) | IL281578A (https=) |
| MA (1) | MA53743A (https=) |
| MX (1) | MX2021002967A (https=) |
| SG (1) | SG11202102105VA (https=) |
| TW (1) | TW202027752A (https=) |
| WO (1) | WO2020069008A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3113689A1 (en) | 2018-09-25 | 2020-04-02 | Antabio Sas | Indane derivatives for use in the treatment of bacterial infection |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200538098A (en) * | 2004-03-22 | 2005-12-01 | Astrazeneca Ab | Therapeutic agents |
| EP1996551A2 (en) * | 2006-03-07 | 2008-12-03 | AstraZeneca AB | Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them. |
| US8278302B2 (en) * | 2009-04-08 | 2012-10-02 | Boehringer Ingelheim International Gmbh | Substituted piperidines as CCR3 antagonists |
| MX2011011080A (es) | 2009-04-22 | 2012-02-23 | Axikin Pharmaceuticals Inc | Antagonistas de ccr3 de arilsulfonamida 2, 5-disustituida. |
| US20160208011A1 (en) * | 2010-01-28 | 2016-07-21 | The Board Of Trustees Of The Leland Stanford Junior University | Ccr3 modulation in the treatment of aging-associated impairments, and compositions for practicing the same |
| UA109290C2 (uk) | 2010-10-07 | 2015-08-10 | Спільні кристали і солі інгібіторів ccr3 | |
| US20130261153A1 (en) * | 2012-04-03 | 2013-10-03 | Boehringer Ingelheim International Gmbh | Use of ccr3-inhibitors |
| US10213421B2 (en) | 2012-04-04 | 2019-02-26 | Alkahest, Inc. | Pharmaceutical formulations comprising CCR3 antagonists |
| MY199462A (en) * | 2017-04-05 | 2023-10-30 | Alkahest Inc | Methods and compositions for treating retina-associated disease using ccr3-inhibitors |
| CN110636844A (zh) * | 2017-04-05 | 2019-12-31 | 万能溶剂有限公司 | 使用ccr3-抑制剂治疗衰老相关损伤的方法及组合物 |
-
2019
- 2019-09-25 KR KR1020217008493A patent/KR20210065950A/ko not_active Withdrawn
- 2019-09-25 EA EA202190463A patent/EA202190463A1/ru unknown
- 2019-09-25 EP EP19867321.2A patent/EP3856195A4/en active Pending
- 2019-09-25 SG SG11202102105VA patent/SG11202102105VA/en unknown
- 2019-09-25 AU AU2019346456A patent/AU2019346456A1/en not_active Abandoned
- 2019-09-25 BR BR112021004938-0A patent/BR112021004938A2/pt not_active Application Discontinuation
- 2019-09-25 WO PCT/US2019/052995 patent/WO2020069008A1/en not_active Ceased
- 2019-09-25 CN CN201980063258.7A patent/CN112789044A/zh active Pending
- 2019-09-25 MA MA053743A patent/MA53743A/fr unknown
- 2019-09-25 JP JP2021517342A patent/JP7528065B2/ja active Active
- 2019-09-25 MX MX2021002967A patent/MX2021002967A/es unknown
- 2019-09-26 TW TW108134938A patent/TW202027752A/zh unknown
-
2021
- 2021-03-17 IL IL281578A patent/IL281578A/en unknown
- 2021-03-23 CL CL2021000724A patent/CL2021000724A1/es unknown
- 2021-03-24 CO CONC2021/0003713A patent/CO2021003713A2/es unknown
-
2024
- 2024-07-24 JP JP2024118649A patent/JP2024153742A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2336275C2 (ru) | Пиримидопроизводные, характеризующиеся антипролиферативной активностью, и фармацевтическая композиция | |
| RU2475487C2 (ru) | Имидазохинолины с иммуномодулирующими свойствами | |
| RU2328486C2 (ru) | Производные 2-пиридона в качестве ингибиторов нейтрофильной эластазы | |
| AR046297A1 (es) | Inhibidores de la dpp - iv metodos para prepararlos y composiciones farmaceuticas que los contienen como agente activo | |
| RU2006112428A (ru) | Производные 2-пиридона в качестве ингибиторов эластазы нейтрофилов и их применение | |
| JP2017507122A5 (https=) | ||
| JP2014037426A5 (https=) | ||
| ME02331B (me) | Derivati benzotiazola kao agensi protiv kancera | |
| NZ627750A (en) | Carbamate compounds and of making and using same | |
| JP2021514001A5 (https=) | ||
| JP2008509187A5 (https=) | ||
| RU2006112427A (ru) | Производные 2-пиридона в качестве ингибиторов эластазы нейтрофилов и их применение | |
| WO2010115836A4 (en) | Substituted piperidines as ccr3 antagonists | |
| RU2009126745A (ru) | Производные сульфонилфенил-2н-{1,2,4}оксадиазол-5-она, способы их получения и их применение в качестве фармацевтических средств | |
| RU2012116877A (ru) | Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы | |
| JP2019506430A5 (https=) | ||
| RU2009133336A (ru) | Пиридопиримидиноновые соединения, применимые при лечении заболеваний или состояний, опосредуемых натриевыми каналами | |
| JP2021528446A5 (https=) | ||
| JP2010513434A5 (https=) | ||
| JP2024517678A5 (https=) | ||
| RU2009103300A (ru) | Производные 2-бензоилимидазопиридинов, их получение и их применение в терапии | |
| JP2021527660A (ja) | ＲＯＲγｔのモジュレータとしてのフェニル及びピリジニル置換イミダゾール | |
| RU2017133660A (ru) | Новые гетероциклические соединения и их применение в профилактике или лечении бактериальных инфекций | |
| JP2025020388A (ja) | Ｂｃｒ－ａｂｌチロシンキナーゼの阻害のための５－及び６－アザインドール化合物 | |
| BR9812239A (pt) | Composto, formulação farmacêutica, uso do composto, processos para o tratamento de distúrbios, para o tratamento de distúrbios mediados por 5-hidroxitriptamina, e, para a preparação do composto |